DW Healthcare Partners, a healthcare-focused private equity firm, announced today that it has completed fundraising for its third fund ("DWHP III"), which has closed with $265 million of committed capital, exceeding its original target of $250 million. DWHP III investors are comprised of pension plans, foundations, fund of funds, high net-worth individuals and family trusts.
DWHP Co-Founder and Managing Director, Andrew Carragher said, "Through our partnerships with talented founders and management teams in our portfolio companies, we have been able to sustain a consistent track record of delivering above-average returns to our investors. As a result, we attracted a great deal of interest while fundraising for Fund III and are pleased that we have exceeded our target. We thank all of our limited partners for their commitment to our firm and look forward to forging new partnerships with innovators, founders, and management teams in the healthcare industry".
During the fundraising period, DWHP completed three Fund III investments, totaling approximately $80 million. Through these investments, DWHP has become equity partners with Z-Medica, a leading developer and manufacturer of innovative hemostatic agents, Health & Safety Institute, one of the leading providers of safety and emergency care content and training, and Med-Pharmex, a leading veterinary drug manufacturer.